"These results almost seem to be too good to be true."

Reducing Iron Stores by Phlebotomy Lowers Cancer Risk in Older Men

NEW YORK (Reuters Health) Jul 08 - Cancer incidence and mortality in
older men may be reduced by repeated phlebotomy to lower serum
ferritin levels, according to findings published online on July 8 in
the Journal of the National Cancer Institute.

Observational studies suggest that lower body iron stores may protect
against malignancy by reducing iron-induced oxidative stress, Dr. Leo
R. Zacharski and his associates note.

To test this possibility, Dr. Zacharski, at the White River Junction
Veterans Affairs Medical Center, Vermont, and his group conducted an
ad hoc analysis of data from a VA study in which patients with
peripheral arterial disease were assigned to repeated blood
collections (n = 636) or to a control group (n = 641), originally for
prevention of atherosclerotic complications .

The population was 99% male, mean age 67 years, with mean ferritin
levels at baseline of 122 ng/mL. Phlebotomy was scheduled every 6
months to maintain ferritin levels between 25 and 60 ng/mL. During a
mean follow-up of 4.5 years, there were 60 new visceral malignancies
in the control patients and 38 in the iron-reduction patients (p =
0.023).

The risk of new malignancy (hazard ratio 0.65, p = 0.036) was
significantly lower in the phlebotomy group. Among patients who did
develop cancer, cancer-specific mortality (HR 0.39, p = 0.003) and all-
cause mortality (HR 0.49, p = 0.009) were lower in the phlebotomy
group.

Overall, 75% of new cancers occurred in patients with mean ferritin
levels > 57 ng/mL.

These findings do not pertain to younger patients without vascular
disease, women, or African Americans, whose ferritin levels are higher
than those of Caucasians, the investigators say. Instead, "these
observations provide incentive for future studies and insight into
optimal clinical trial design."

Dr. Zacharski's team suggests "there may be a need to redefine the
normal range for the serum ferritin level based on associated disease
risk." They also call for re-evaluation of the policy of routinely
administering iron to anemic cancer patients.

In a related editorial, Dr. Mads Melbye, at Statens Serum Institut in
Copenhagen and colleagues suggest that "these results almost seem to
be too good to be true."

While recommending that "all possibilities for bias must be carefully
examined" and that "the results have to be interpreted with caution,"
the editorialists also support more research on this topic.

Furthermore, they write, "a cautious standpoint toward iron
supplementation where no proper indication exists is perhaps
advisable."

J Natl Cancer Inst 2008;100.

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://tinyurl.com/2r2nkh

Man Is A Herbivore!
http://tinyurl.com/4rq595

DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk